Opioids: A Prospective Assessment of Opioid Utilization Post-operatively in Sports Orthopaedic Surgeries

Sponsor
St. Louis University (Other)
Overall Status
Completed
CT.gov ID
NCT03422211
Collaborator
(none)
223
3
11.5
74.3
6.4

Study Details

Study Description

Brief Summary

There was a study titled "A prospective evaluation of opioid utilization after upper extremity surgical procedures: Identifying consumption patterns and determining prescribing guidelines" by Dr. Matzon and team from Thomas Jefferson University that came up with a simple set of opioid guidelines post-surgically. These guidelines are helping to guide surgeon's prescribing patterns and ideally limit the number of prescribed pain medicines. We plan to identify typical narcotic analgesic usage post sports orthopaedic surgery. We hope to identify the number of narcotic pain pills to prescribe to patients undergoing orthopaedic sports surgery in the future.

Detailed Description

1, Consent patients undergoing sports orthopaedic surgery in clinic or in pre-operative holding area and also administer first questionnaire, opioid risk tool, and pain catastrophizing scale(research) 2. Sports orthopaedic surgery (standard of care) 3. Post-op pain control regimen (standard of care) 4. Call or email patient with questionnaire every day for a week followed by weekly for 7 more weeks. The children's questionnaire will be child specific and the parent will assist the child. Will also use a picture of Wong-Baker Faces to help children identify where their pain scale is which will be given to the patient the same day that the consent is obtained to use at home(research). Questionnaire should take less than 5 minutes and will include questions about how well their pain is controlled, how many analgesic medications they have taken, and if they have tried anything else for pain. (Research) 5. Patient will continue to go to post-operative appointments as scheduled. (standard of care) 6. Will store the data from the phone calls on the secured T drive. (Research)

Study Design

Study Type:
Observational
Actual Enrollment :
223 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Prospective Assessment of Opioid Utilization Post-operatively in Sports Orthopaedic Surgeries
Actual Study Start Date :
Nov 16, 2017
Actual Primary Completion Date :
Nov 2, 2018
Actual Study Completion Date :
Nov 2, 2018

Arms and Interventions

Arm Intervention/Treatment
Sports orthopaedic surgery

Patients that recently underwent orthopaedic sports surgery performed by two separate surgeons

Other: Questionnaire
Will ask patients questions in regards to how many narcotics they have taken and what their pain level has been.

Outcome Measures

Primary Outcome Measures

  1. Number of narcotic analgesics consumed [2 months]

    Quantify narcotic analgesics

Eligibility Criteria

Criteria

Ages Eligible for Study:
10 Years to 100 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • analgesics prescribed to patient

Patients that have undergone orthopaedic sports surgeries that Dr. Kaar and Dr. Kim performed with some of the examples being:

Acromioplasty Rotator cuff repair Labral repair Proximal humerus repair versus arthroplasty Elbow instability repair Elbow arthroplasty Hip arthroscopy Hip cam lesion repair Knee arthroscopy Knee ligament repair Knee meniscus repair Achilles tendon repair Cartilage preserving procedures

Exclusion Criteria:

mental retardation inmates non-english speaking pregnant on-call trauma cases

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cardinal Glennon Saint Louis Missouri United States 63104
2 Anheuser Busch Institute Saint Louis Missouri United States 63110
3 SSM Health St. Mary's Hospital - St. Louis Saint Louis Missouri United States 63117

Sponsors and Collaborators

  • St. Louis University

Investigators

  • Principal Investigator: John M Capelle, MD, St. Louis University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
John Capelle, MD, Medical Doctor - Researcher, St. Louis University
ClinicalTrials.gov Identifier:
NCT03422211
Other Study ID Numbers:
  • 28494
First Posted:
Feb 5, 2018
Last Update Posted:
Sep 24, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 24, 2021